Fen Zhang
Jinhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serpine1 Mediates Cardiac Fibrosis Following Myocardial Ischemia-Reperfusion Injury by Activating the Endothelial-Mesenchymal Transition Process and Inducing Mitochondrial Damage.
Journal: Shock (Augusta, Ga.)
Published: March 26, 2026
Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High-Glucose Environment by Activating the AMPK/PGC-1α/SIRT3 Signalling Pathway.
Journal: Clinical and experimental pharmacology & physiology
Published: December 25, 2025
m6A-modified ATF4 regulates glucose/lipid metabolism via the Sestrin2/GSK3β axis to alleviate myocardial ischemia-reperfusion injury.
Journal: Journal of cardiothoracic surgery
Published: August 20, 2025
Mitophagy as a therapeutic target for myocardial fibrosis: Mechanistic insights and potential pharmacological interventions.
Journal: Pakistan journal of pharmaceutical sciences
Published: June 25, 2025
Exploration of Pharmacological Mechanisms of Dapagliflozin against Type 2 Diabetes Mellitus through PI3K-Akt Signaling Pathway based on Network Pharmacology Analysis and Deep Learning Technology.
Journal: Current computer-aided drug design
Published: August 14, 2023
Association between circulating leukocytes and arrhythmias: Mendelian randomization analysis in immuno-cardiac electrophysiology.
Journal: Frontiers in immunology
Published: September 11, 2022
Association of the MYH6 Gene Polymorphism with the Risk of Atrial Fibrillation and Warfarin Anticoagulation Therapy.
Journal: Genetic testing and molecular biomarkers
Published: September 13, 2021
Angiopoietin-like protein 4 treated bone marrow-derived mesenchymal stem cells alleviate myocardial injury of patients with myocardial infarction.
Journal: Nursing & health sciences
Published: August 02, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026